Home › Funds › Rangeley Capital, LLC › BCYC

Rangeley Capital, LLC position in BCYC

BICYCLE THERAPEUTICS PLC · Health Care

Rangeley Capital, LLC reported holding 253,500 shares of BCYC (BICYCLE THERAPEUTICS PLC) in its Q2 2026 13F filing — a position valued at US$1.1M, representing 1.02% of its reported portfolio and ranking #28 among its reported holdings. Rangeley Capital, LLC has disclosed BCYC holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)253.50K sh
Reported value held$1.07M
Portfolio Weight1.02%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rangeley Capital, LLC's BCYC position evolved

Rangeley Capital, LLC first disclosed a stake in BCYC in Q2 2025 at 75,000 shares (US$521K). The position peaked in Q1 2026 at 232,260 shares, worth US$1.1M. Across 5 filings, Rangeley Capital, LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 253,500 shares valued at US$1.1M — an increase of 21,240 shares quarter over quarter.. Notable position changes include a 73% increase in Q3 2025 (shares fell 9% over the following quarter), a 76% increase in Q1 2026 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 75.00K $521.25K New
Q3 2025 130.00K $1.01M Add
Q4 2025 132.00K $934.56K Add
Q1 2026 232.26K $1.08M Add
Q2 2026 253.50K $1.07M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCYC and 13F data

BCYC (BICYCLE THERAPEUTICS PLC) is a Health Care company. 11 other funds we track also report a position in BCYC — the largest reported positions include BAKER BROS. ADVISORS LP (US$46.2M), FCPM III SERVICES B.V. (US$14.7M), Long Focus Capital Management, LLC (US$14.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCYC

All BCYC fund holders →

FAQ

How long has Rangeley Capital, LLC held BCYC?

Rangeley Capital, LLC has disclosed BCYC holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Rangeley Capital, LLC's current position in BCYC?

As of Q2 2026, Rangeley Capital, LLC holds 253.50K shares of BCYC (BICYCLE THERAPEUTICS PLC), valued at $1.07M, representing 1.02% of its reported portfolio and ranking #28.

Has Rangeley Capital, LLC been buying or selling BCYC?

In the latest 13F filing (Q2 2026), Rangeley Capital, LLC increased its position in BCYC. The position peaked in Q1 2026 at 232.26K shares.

Which other funds hold BCYC?

Other major institutional holders of BCYC include BAKER BROS. ADVISORS LP, FCPM III SERVICES B.V., Long Focus Capital Management, LLC, among 11 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.